- Home
- LYB vs STE Comparison
LYB vs STE Comparison
Compare LYB & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- STE
- Stock Information
- Founded
- LYB 1955
- STE 1985
- Country
- LYB United States
- STE United States
- Employees
- LYB N/A
- STE N/A
- Industry
- LYB Major Chemicals
- STE Industrial Specialties
- Sector
- LYB Industrials
- STE Health Care
- Exchange
- LYB Nasdaq
- STE Nasdaq
- Market Cap
- LYB 20.3B
- STE 23.0B
- IPO Year
- LYB N/A
- STE 1992
- Fundamental
- Price
- LYB $53.38
- STE $245.63
- Analyst Decision
- LYB Hold
- STE Buy
- Analyst Count
- LYB 14
- STE 9
- Target Price
- LYB $65.71
- STE $268.25
- AVG Volume (30 Days)
- LYB 5.9M
- STE 598.9K
- Earning Date
- LYB 08-01-2025
- STE 08-06-2025
- Dividend Yield
- LYB 10.27%
- STE 0.93%
- EPS Growth
- LYB N/A
- STE 61.94
- EPS
- LYB 0.77
- STE 6.53
- Revenue
- LYB $38,655,000,000.00
- STE $5,571,115,000.00
- Revenue This Year
- LYB N/A
- STE $7.78
- Revenue Next Year
- LYB $2.80
- STE $6.07
- P/E Ratio
- LYB $115.30
- STE $37.55
- Revenue Growth
- LYB 2.98
- STE 6.42
- 52 Week Low
- LYB $47.55
- STE $200.98
- 52 Week High
- LYB $99.36
- STE $252.79
- Technical
- Relative Strength Index (RSI)
- LYB 43.64
- STE 64.80
- Support Level
- LYB $47.55
- STE $220.55
- Resistance Level
- LYB $52.88
- STE $248.06
- Average True Range (ATR)
- LYB 2.41
- STE 4.25
- MACD
- LYB -0.16
- STE 2.45
- Stochastic Oscillator
- LYB 38.20
- STE 91.17
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.